1E Therapeutics vs Insitro
1E Therapeutics vs Insitro, compared side by side on 21 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: 1E Therapeutics is on 48/100 and Insitro on 62/100.
Where each one leads
1E Therapeutics
- headcount growth: +18.6% against +10.9%
Insitro
- our overall score: 62/100 against 48/100
- agent readiness: 40/100 against 32/100
- domain rating: 64/100 against 20/100
- headcount: 255 against 49
- funding raised: $243M against $120M
- LinkedIn following: 42,173 against 3,258
At a glance
| Measure | 1E Therapeutics | Insitro |
|---|---|---|
| What it is | Drug development company creating first-in-class RNA-targeting therapeutics using a proprietary platform. | Data-driven drug discovery and development company using machine learning and high-throughput biology. |
| Category | Drug Development, Life Sciences, Therapeutics, RNA-Targeting | Healthcare, Drug Discovery, Drug Development, DNA |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2020 | 2018 |
| Headquarters | Not published | South San Francisco, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | 1E Therapeutics | Insitro |
|---|---|---|
| Employees | 49 | 255 |
| Headcount growthLast 12 months | +18.6% | +10.9% |
| Total funding | $120M | $243M |
| Latest round | Seed | Series B |
| Valuation | Not published | $7.0B |
| LinkedIn followers | 3,258 | 42,173 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | 1E Therapeutics | Insitro |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 48/100 | 62/100 |
| Traction | 57/100 | 60/100 |
| Team | 50/100 | 50/100 |
| Community | Not published | 8/100 |
| Search visibility | 39/100 | 62/100 |
| Quality | 45/100 | 65/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (32/100) | D (40/100) |
| Domain ratingLink authority, 0-100 | 20/100 | 64/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | 1E Therapeutics | Insitro |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Jquery | Jquery |
1E Therapeutics vs Insitro: common questions
Which is better, 1E Therapeutics or Insitro?
On our 0-100 score Insitro rates higher (62/100 against 48/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 21 data points above: read the rows that match what you are buying for.
How do 1E Therapeutics and Insitro compare on the numbers?
1E Therapeutics leads on headcount growth (+18.6% against +10.9%). Insitro leads on our overall score (62/100 against 48/100), agent readiness (40/100 against 32/100), domain rating (64/100 against 20/100), headcount (255 against 49), funding raised ($243M against $120M), LinkedIn following (42,173 against 3,258).
Read the full 1E Therapeutics review and pricing or the Insitro review and pricing. You can also browse other 1E Therapeutics alternatives we track.